Physician profile
Steven Smith
NPI 1861681611
$1,457.07
in general payments reported to CMS, 2019-2025
17 companies · $99.31 in 2025
The $99.31 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $144 · 2021: $458 · 2022: $292 · 2023: $157 · 2024: $172 · 2025: $99.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $314.14 | 2021-2024 | Qelbree, Qelbree |
| Pfizer INC. | $198.42 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $168.18 | 2020-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Takeda Pharmaceuticals U.S.A., INC. | $149.57 | 2020-2021 | |
| Glaxosmithkline, LLC. | $148.02 | 2021-2024 | Bexsero |
| Ironshore Pharmaceuticals INC. | $105.99 | 2019-2024 | Jornay Pm |
| Corium, LLC | $81.60 | 2022-2024 | Azstarys |
| Tris Pharma INC | $60.73 | 2021-2025 | Onyda Xr |
| Kaleo, INC. | $46.30 | 2021 | |
| Organon LLC | $32.84 | 2022 | |
| Sobi, INC | $31.51 | 2021-2022 | |
| Adlon Therapeutics L.P. | $27.84 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $26.59 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $19.79 | 2025 | Jornay Pm |
| Cipher Pharmaceuticals US LLC | $17.09 | 2025 | Natroba, Spinosad |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.24 | 2025 | |
| Sanofi Pasteur INC. | $14.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.